Targeting eIF4A1-dependent HK2 translation axis for prevention of castration-resistant prostate cancer
靶向 eIF4A1 依赖性 HK2 翻译轴预防去势抵抗性前列腺癌
基本信息
- 批准号:10307097
- 负责人:
- 金额:$ 38.67万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-12-01 至 2023-11-30
- 项目状态:已结题
- 来源:
- 关键词:5&apos Untranslated RegionsAKT1 geneAblationAndrogen ReceptorAndrogensBinding SitesBiologicalCRISPR/Cas technologyCancer EtiologyCancer PatientCancer cell lineCastrationCessation of lifeChemopreventionClinicalComplexCrystallizationDataDeoxyglucoseDevelopmentDoxycyclineG-QuartetsGenerationsGenesGeneticGenetic Models for CancerGenetic TranscriptionGenetic TranslationGenetic studyGlucoseGlucose-6-PhosphateGlycolysisGoalsHexokinase 2HumanIntronsKnock-outLentivirusMalignant neoplasm of prostateMediatingMedical CastrationMessenger RNAMetastatic Prostate CancerMolecularMusMutagenesisMutationNormal CellOccupationsPTEN genePatientsPharmaceutical PreparationsPharmacologyPlayPreventionProtein BiosynthesisProteinsProto-Oncogene Proteins c-aktPublishingRNAReceptor SignalingResistance developmentRoleSecondary PreventionStructureSystemTP53 geneTestingTissuesToxic effectTranslationsTumor Suppressor GenesUnited StatesWarburg Effectandrogen deprivation therapyantagonistbasecastration resistant prostate cancerclinical applicationdrug developmentdruggable targetenzalutamideglucose metabolismin vivoinhibitorinnovationmRNA Transcript Degradationmennovelnovel therapeuticspatient derived xenograft modelpre-clinicalpreclinical developmentpreventprostate cancer cellprostate cancer cell lineprostate cancer modelprostate cancer progressionprotein expressionpublic health relevanceside effectsilvestrolsmall hairpin RNAstandard of caretranslational impacttumor growth
项目摘要
Project Summary/Abstract
Our overarching goal is to identify a novel mechanism-driven chemoprevention strategy that can effectively
prevent or delay the development and progression of currently incurable castration-resistant prostate cancer
(CRPC) to revolutionize long-term survival. In the United States, prostate cancer strikes one in six men and is
the second leading cause of cancer-related deaths in men. Clinically, androgen deprivation therapy (ADT) with
surgical or medical castration remains standard-of-care for advanced/metastatic prostate cancer for decades.
Despite its efficacy in the short term, ADT is inevitably followed by the development of CRPC in the majority of
patients. The discovery that persistent AR signaling axis plays a crucial role in CRPC led to FDA-approval of
“second-generation” ADT drugs, such as the novel AR antagonist enzalutamide/Xtandi, providing 4-5 months
survival benefits. However, nearly all the patients will develop resistance to these new drugs within 6 to 12
months. Thus, development of CRPC following ADT is a major clinical problem but presents a unique window
for innovative secondary/tertiary chemoprevention. We demonstrate that Warburg effect caused by the
elevated hexokinase 2 (HK2), which catalyzes the irreversible first step of glycolysis by phosphorylating
glucose to glucose-6-phosphate (G-6-P), is required for tumor growth of CRPC. Accordingly, targeting HK2
enzymatic activity could prevent or delay CRPC. Unfortunately, current HK2 inhibitors, such as 2-deoxyglucose
(2-DG), are not specific with side effects due to inhibition of ubiquitously expressed HK1, which is required for
glucose metabolism of normal cells. Based on our published data and preliminary studies, we hypothesize
that inhibition of HK2-mediated Warburg effect by targeting eIF4A1-dependent HK2 protein synthesis prevents
or delays CRPC progression. We will test this central hypothesis by accomplishing 3 specific aims. Aim 1 is to
structurally elucidate the molecular mechanism underlying eIF4A1-dependent HK2 mRNA translation in CRPC.
Aim 2 is to genetically demonstrate that targeting eIF4A1 blocks HK2 mRNA translation to prevent tumor
growth of CRPC in vivo; and Aim 3 is to pharmacologically demonstrate that eIF4A1specific inhibitor silvestrol
blocks HK2 mRNA translation to prevent tumor growth in preclinical CRPC models. Successful
accomplishment of the proposed studies will provide Proof-of-Principle that targeting eIF4A1-HK2 translation
axis serves as a mechanisms-driven novel and actionable strategy to prevent CRPC progression at structural,
genetic and pharmacological levels.
项目总结/摘要
我们的首要目标是确定一种新的机制驱动的化学预防策略,可以有效地
预防或延缓目前无法治愈的去势抵抗性前列腺癌的发展和进展
(CRPC)彻底改变长期生存。在美国,前列腺癌袭击六分之一的男性,
男性癌症相关死亡的第二大原因。临床上,雄激素剥夺治疗(ADT)
几十年来,手术或药物去势仍然是晚期/转移性前列腺癌的护理标准。
尽管ADT在短期内有效,但在大多数患者中,ADT不可避免地会发展为CRPC。
患者持续性AR信号传导轴在CRPC中起关键作用的发现导致FDA批准
“第二代”ADT药物,如新型AR拮抗剂Enzalutamide/Xtandi,提供4-5个月的
生存福利。然而,几乎所有的患者都会在6 - 12年内对这些新药产生耐药性。
个月因此,ADT后CRPC的发展是一个主要的临床问题,但存在一个独特的窗口
创新的二级/三级化学预防。我们证明了由非线性引起的瓦尔堡效应
升高的己糖激酶2(HK 2),通过磷酸化催化糖酵解的不可逆的第一步
葡萄糖转化为葡萄糖-6-磷酸(G-6-P)是CRPC肿瘤生长所需的。因此,针对HK 2
酶活性可以预防或延迟CRPC。不幸的是,目前的HK 2抑制剂,如2-脱氧葡萄糖,
(2-DG),由于抑制普遍表达的HK 1而不是特异性的副作用,HK 1是
正常细胞的葡萄糖代谢。根据我们公布的数据和初步研究,我们假设
通过靶向eIF 4A 1依赖性HK 2蛋白合成抑制HK 2介导的瓦尔堡效应,
或延迟CRPC进展。我们将通过实现三个具体目标来检验这个中心假设。目标1:
从结构上阐明CRPC中eIF 4A 1依赖性HK 2 mRNA翻译的分子机制。
目的2是从遗传学上证明靶向eIF 4A 1阻断HK 2 mRNA翻译以预防肿瘤
目的3是证实eIF 4A 1特异性抑制剂司维司群
在临床前CRPC模型中阻断HK 2 mRNA翻译以防止肿瘤生长。成功
完成拟议研究将提供针对eIF 4A 1-HK 2翻译的原则证明
轴作为一种机制驱动的新的和可行的策略,以防止CRPC进展的结构,
遗传和药理水平。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
YIBIN DENG其他文献
YIBIN DENG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('YIBIN DENG', 18)}}的其他基金
Targeting eIF4A1-dependent HK2 translation axis for prevention of castration-resistant prostate cancer
靶向 eIF4A1 依赖性 HK2 翻译轴预防去势抵抗性前列腺癌
- 批准号:
10051412 - 财政年份:2018
- 资助金额:
$ 38.67万 - 项目类别:
Targeting eIF4A1-dependent HK2 translation axis for prevention of castration-resistant prostate cancer
靶向 eIF4A1 依赖性 HK2 翻译轴预防去势抵抗性前列腺癌
- 批准号:
10531862 - 财政年份:2018
- 资助金额:
$ 38.67万 - 项目类别:
Gain of function mutant p53 in telomere uncapping-driven breast tumorigenesis
端粒脱帽驱动的乳腺肿瘤发生中功能突变体 p53 的获得
- 批准号:
8153821 - 财政年份:2011
- 资助金额:
$ 38.67万 - 项目类别:
Gain of function mutant p53 in telomere uncapping-driven breast tumorigenesis
端粒脱帽驱动的乳腺肿瘤发生中功能突变体 p53 的获得
- 批准号:
8539347 - 财政年份:2011
- 资助金额:
$ 38.67万 - 项目类别:
Gain of function mutant p53 in telomere uncapping-driven breast tumorigenesis
端粒脱帽驱动的乳腺肿瘤发生中功能突变体 p53 的获得
- 批准号:
8907720 - 财政年份:2011
- 资助金额:
$ 38.67万 - 项目类别:
Prevention of PTEN deletion driven prostate cancer by selenium
硒预防 PTEN 缺失导致的前列腺癌
- 批准号:
8206703 - 财政年份:2010
- 资助金额:
$ 38.67万 - 项目类别:
Prevention of PTEN deletion driven prostate cancer by selenium
硒预防 PTEN 缺失导致的前列腺癌
- 批准号:
8028115 - 财政年份:2010
- 资助金额:
$ 38.67万 - 项目类别:
相似海外基金
Impact of alternative polyadenylation of 3'-untranslated regions in the PI3K/AKT cascade on microRNA
PI3K/AKT 级联中 3-非翻译区的替代多聚腺苷酸化对 microRNA 的影响
- 批准号:
573541-2022 - 财政年份:2022
- 资助金额:
$ 38.67万 - 项目类别:
University Undergraduate Student Research Awards
How do untranslated regions of cannabinoid receptor type 1 mRNA determine receptor subcellular localisation and function?
1 型大麻素受体 mRNA 的非翻译区如何决定受体亚细胞定位和功能?
- 批准号:
2744317 - 财政年份:2022
- 资助金额:
$ 38.67万 - 项目类别:
Studentship
MICA:Synthetic untranslated regions for direct delivery of therapeutic mRNAs
MICA:用于直接递送治疗性 mRNA 的合成非翻译区
- 批准号:
MR/V010948/1 - 财政年份:2021
- 资助金额:
$ 38.67万 - 项目类别:
Research Grant
Translational Control by 5'-untranslated regions
5-非翻译区域的翻译控制
- 批准号:
10019570 - 财政年份:2019
- 资助金额:
$ 38.67万 - 项目类别:
Translational Control by 5'-untranslated regions
5-非翻译区域的翻译控制
- 批准号:
10223370 - 财政年份:2019
- 资助金额:
$ 38.67万 - 项目类别:
Translational Control by 5'-untranslated regions
5-非翻译区域的翻译控制
- 批准号:
10455108 - 财政年份:2019
- 资助金额:
$ 38.67万 - 项目类别:
Synergistic microRNA-binding sites, and 3' untranslated regions: a dialogue of silence
协同的 microRNA 结合位点和 3 非翻译区:沉默的对话
- 批准号:
255762 - 财政年份:2012
- 资助金额:
$ 38.67万 - 项目类别:
Operating Grants
Analysis of long untranslated regions in Nipah virus genome
尼帕病毒基因组长非翻译区分析
- 批准号:
20790351 - 财政年份:2008
- 资助金额:
$ 38.67万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Search for mRNA elements involved in the compatibility between 5' untranslated regions and coding regions in chloroplast translation
寻找参与叶绿体翻译中 5 非翻译区和编码区之间兼容性的 mRNA 元件
- 批准号:
19370021 - 财政年份:2007
- 资助金额:
$ 38.67万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Post-transcriptional Regulation of PPAR-g Expression by 5'-Untranslated Regions
5-非翻译区对 PPAR-g 表达的转录后调控
- 批准号:
7131841 - 财政年份:2006
- 资助金额:
$ 38.67万 - 项目类别: